Long-term complete response after transcatheter arterial chemoembolization and stereotactic body radiation therapy in a patient with hepatocellular carcinoma at the caudate lobe

about

Long-term complete response after transcatheter arterial chemoembolization and stereotactic body radiation therapy in a patient with hepatocellular carcinoma at the caudate lobe

Item

http://www.wikidata.org/entity/Q58781361

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Long-term complete response af ...... carcinoma at the caudate lobe

@en

Long-term complete response af ...... carcinoma at the caudate lobe

@nl

type

Item

label

Long-term complete response af ...... carcinoma at the caudate lobe

@en

Long-term complete response af ...... carcinoma at the caudate lobe

@nl

prefLabel

Long-term complete response af ...... carcinoma at the caudate lobe

@en

Long-term complete response af ...... carcinoma at the caudate lobe

@nl

P1476

Long-term complete response af ...... carcinoma at the caudate lobe

@en

P2093

Gi-Young Ko

http://www.w3.org/2001/XMLSchema#string

Sang Min Yoon

http://www.w3.org/2001/XMLSchema#string

Shin Hwang

http://www.w3.org/2001/XMLSchema#string

Yong-Kyu Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines

Hepatocellular carcinoma

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.

Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.

Choice of approach for hepatectomy for hepatocellular carcinoma located in the caudate lobe: isolated or combined lobectomy?

Anterior hepatic transection for caudate lobectomy.

Isolated caudate lobe resection: technical challenges.

Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.

Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma.

P304

274-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.14701/AHBPS.2018.22.3.274

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30215050

http://www.w3.org/2001/XMLSchema#string

P932

6125267

http://www.w3.org/2001/XMLSchema#string